Mutations in the IDH1/2 have been identified in gliomas, and IDH-mutant low-grade gliomas (LGGs) may develop malignant transformation after further genetic alterations, such as Myc, PTEN, KRAS, PIK3CA, and MET, are acquired. The gene discussed is PIK3CA; the disease is central nervous system cancer.